+13.1%
GSK vs COMP
+23.8%
-10.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | COMP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +7.7% | -2.7% | +4.7% |
| 7D | +4.9% | +9.5% | -4.5% | +4.5% |
| 30D | +9.9% | +8.1% | +1.8% | +9.4% |
| 3M | +0.2% | -16.3% | +16.5% | +0.5% |
| 6M | +2.3% | +42.2% | -39.9% | +1.1% |
| YTD | +7.1% | -5.0% | +12.1% | +4.8% |
| 1Y | +13.1% | +20.1% | -7.0% | +7.8% |
| All | +13.1% | +23.8% | -10.7% | +7.8% |
Cumulative growth
Daily Returns
Daily percentage return beside COMP.
Daily Out/Under-Performance
Portfolio return minus COMP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × COMP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded COMP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling